Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 76 Neoplasm Metastasis 13 Stomach Neoplasms 12 Neoplasms 8 Breast Neoplasms, Male 8 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Brain Neoplasms 5 Ovarian Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Squamous Cell Carcinoma of Head and Neck 3 Inflammatory Breast Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Vulvar Neoplasms 2 Vipoma 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Urethral Neoplasms 2 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Testicular Neoplasms 2 Somatostatinoma 2 Solid Tumor 2

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × HER2 Positive Breast Cancer × Trastuzumab × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡